Clinical Trial Details
| Trial ID: | L7008 |
| Source ID: | NCT01628445 |
| Associated Drug: | Liraglutide |
| Title: | Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin |
| Acronym: | SAIL |
| Status: | TERMINATED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes |
| Interventions: | DRUG: liraglutide|DRUG: placebo injection |
| Outcome Measures: | Primary: Change in A1c, Baseline to 24 wks | Secondary: Percentage of patients experiencing hypoglycemia, Baseline and 24 weeks|Change in Systolic Blood pressure, Baseline and 24 weeks|Change in diastolic blood pressure, Baseline and 24 weeks|Change in waist circumference, Baseline and 24 weeks|Change in body weight, Baseline and 24 weeks|Change in heart rate, Baseline and 24 weeks|Change in lipid profile, Baseline and 24 weeks|Diabetes Treatment Satisfaction, Baseline, 12 weeks and 24 weeks|Percentage of patients achieving A1C < or equal to 7%, Baseline and 24 weeks|Change in fasting blood glucose, Baseline adn 24 weeks|Occurence of undetected hypoglycemia as measured by continuous glucose monitoring, Baseline, 12 weeks and 24 weeks|Postprandial glucose reduction through measurement of 7 point glucose profile, Baseline, 4 weeks, 12 weeks and 24 weeks |
| Sponsor/Collaborators: | Sponsor: University of Manitoba | Collaborators: Novo Nordisk A/S |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE3 |
| Enrollment: | 52 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT |
| Start Date: | 2012-08 |
| Completion Date: | 2015-11 |
| Results First Posted: | |
| Last Update Posted: | 2016-01-21 |
| Locations: | Winnipeg Regional Health Authority Health Sciences Centre Winnipeg Diabetes Research Group, Winnipeg, Manitoba, R3E3P4, Canada |
| URL: | https://clinicaltrials.gov/show/NCT01628445 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|